IPO Timeline
Broker Results (T-2)
2022-07-04
Some brokers release in afternoon
Grey Market (T-1)
2022-07-05
Afternoon
HKEX Allotment (T-1)
2022-07-05
Evening
Registrar Allotment (T-1)
2022-07-05
Evening
Listing Day (T)
2022-07-06
First day of trading
Company Overview
| Stock Name | 智雲健康科技集團 |
| Stock Code | 09955 |
| Company Full Name | 智雲健康科技集團 |
| Industry | 軟件服務 |
| Principal Activities | 主要在中國從事提供慢病管理解決方案,包括為醫院與藥店提供醫療用品供應和軟件即服務(SaaS)、為制藥公司提供數字營銷服務,以及為患者提供在線問診和處方開具。 |
| Listing Date | 2022-07-06 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省杭州市余杭區五常街道文一西路998號海創園4樓401、403及405A室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.cloudr.cn |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism |
To be extracted
|
| Offer Price | HK$ 30.50 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 61.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 57,950,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 28.2 |
| First Day Open | HK$ 30.5 |
| First Day Change | -7.54% |
| First Day Volume | 4275800.0 |
| First Day Turnover | 119515000.0 |
Use of Proceeds
| Use of Proceeds | 1、約60%預計將用于業務擴張,在全國范圍內擴大我們的醫院網絡;
2、約25%預計將用于提高我們的醫學知識和技術能力,以加強我們在數字醫療行業的領導地位;
3、約5%預計將用于通過戰略伙伴關系、投資和收購其他業務來擴大我們的生態系統,以補充我們的有機成長戰略;
4、約10%預計將用于營運資金和一般公司用途。 |
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
J.P. Morgan Securities (Far East) Limited CE AAB026
Overall Coordinators (4)
摩根士丹利亚洲有限公司 CE AAD291
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
中国国际金融香港证券有限公司 CE AEN894
招银国际融资有限公司 CE AVM940
Joint Bookrunners (5)
摩根士丹利亚洲有限公司 CE AAD291
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
中国国际金融香港证券有限公司 CE AEN894
招银国际融资有限公司 CE AVM940
华盛资本证券有限公司 CE AUL711
Joint Lead Managers (5)
摩根士丹利亚洲有限公司 CE AAD291
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
中国国际金融香港证券有限公司 CE AEN894
招银国际融资有限公司 CE AVM940
华盛资本证券有限公司 CE AUL711
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
Harvest International Premium Value (Secondary Market) Fund SPC |
156,998,750 HKD |
— |
27.09% |
— |
6 months |
2023-01-06 |
| 2 |
Sanofi Foreign Participations B.V |
117,748,300 HKD |
— |
20.32% |
— |
6 months |
2023-01-06 |
| 3 |
Tasly International Capital Limited |
39,247,400 HKD |
— |
6.77% |
— |
6 months |
2023-01-06 |
| 4 |
扬子江(香港)有限公司 |
39,247,400 HKD |
— |
6.77% |
— |
6 months |
2023-01-06 |
Directors & Management
| Chairman | 匡明 |
| Company Secretary | 馮慧森 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 匡明及關連人士(15.23%);Prime Forest Assets Limited(12.49%);上海旗驥科技合伙企業(有限合伙)(5.47%);SIG Global China Fund I, LLLP(5.38%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.